Elevate Your Business to the Next Level with Xentria Inc.

Perkins Coie is pleased to have advised Xentria Inc., a clinical-stage biotherapeutics company dedicated to developing novel therapeutics to address unmet ... Xentria Inc. has entered into an exclusive license agreement with New York University (NYU) securing Xentria exclusive rights related to the ... Xellia is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Xentria is a biotech company focused on developing novel therapeutics to address unmet clinical needs. With this funding, the company advance the Xentria pipeline and execute against the goal of developing critical therapeutics for patients in ... PRNewswire/ -- Xentria, Inc. (Xentria), a clinical-stage biotherapeutics company focused on advancing drug development to address unmet ... Xentria, a Chicago, IL-based biotech company, raised $25M in Equity funding. Xentria COO Kirsten Anderson and Meitheal CEO and president of Xentria Tom Shea ... Crain Communications, Inc. All Rights Reserved. ... Xentria, Inc. | Not yet recruiting ➔ Enrolling by invitation. Enrollment open • Immunology • Sarcoidosis. Print; Email; More sharing. Reddit · StumbleUpon. Xentria ... Focused on becoming a critical leader in the biopharma industry through a strong portfolio of products having purpose for patients. Driven to treat ...